HFA Premium Access

Integrated transcriptomic and regulatory RNA sequencing and machine-learning driven analyses identify molecular signatures underlying human heart failure

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Congress Presentation

About the speaker

Doctor Jyoti Gulia

Biocon Bristol Myers Squibb Research Center (Syngene International Ltd), Bengaluru (India)
0 follower

7 more presentations in this session

The usefulness of end-expiratory oxygen partial pressure as a prognostic indicator in patients with heart failure with reduced ejection fraction

Speaker: Doctor T. Nakade (Tokyo, JP)

Thumbnail

SGLT2 inhibitors in heart failure with reduced ejection fraction without diabetes mellitus: why are patients outside the magic circle?

Speaker: Doctor D. Santoro (Bari, IT)

Thumbnail

Impact of prolonged use of angiotensin receptor-neprilysin inhibitors versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with heart failure reduced ejection frac

Speaker: Assistant Professor B. PARK (Daegu, KR)

Thumbnail

Cardiac amyloidosis patients with reduced ejection fraction have an increase morbimortality

Speaker: Doctor F. Bauer (Rouen, FR)

Thumbnail

Ivabradine improves survival in children with severe chronic heart failure

Speaker: Doctor R. Adorisio (Rome, IT)

Thumbnail

Access the full session

Heart failure with reduced ejection fraction (HFrEF) 2

Speakers: Doctor J. Gulia, Doctor T. Nakade, Doctor D. Santoro, Assistant Professor B. PARK, Doctor F. Bauer...
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb